Indivior Pharmaceuticals, Inc. (INDV)
NASDAQ: INDV · Real-Time Price · USD
39.29
+0.21 (0.54%)
Aug 18, 2026, 2:11 PM EDT - Market open

Indivior Pharmaceuticals Balance Sheet

Millions USD. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
2221953193167741,102
Short-Term Investments
--194109-
Trading Asset Securities
----10-
Cash & Short-Term Investments
2221953204108931,102
Cash Growth
-56.47%-39.06%-21.95%-54.09%-18.97%28.44%
Accounts Receivable
271253254254220202
Other Receivables
16233-513
Receivables
287255287254225215
Inventory
15015316713511495
Prepaid Expenses
143431521418
Other Current Assets
5215224151314
Total Current Assets
7256528271,2661,2591,444
Property, Plant & Equipment
1831701391248595
Long-Term Investments
2728274198-
Other Intangible Assets
226137082
Long-Term Deferred Tax Assets
271323277288219105
Other Long-Term Assets
2526402838106
Total Assets
1,2331,2011,3161,7601,7691,832

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Accounts Payable
304863393326
Accrued Expenses
786784715700584694
Current Portion of Long-Term Debt
-2918333
Current Portion of Leases
91010988
Current Income Taxes Payable
3027897
Other Current Liabilities
134111153138266
Total Current Liabilities
8689149241,2901,019804
Long-Term Debt
487290315237237239
Long-Term Leases
132232342936
Other Long-Term Liabilities
7373382390433550
Total Liabilities
1,4411,2991,6531,9511,7181,629

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Common Stock
-6262686870
Additional Paid-In Capital
155112908887
Retained Earnings
-334-243-443-2951,3031,438
Comprehensive Income & Other
-29-29-46-52-1,328-1,312
Shareholders' Equity
-208-98-337-19151203
Total Liabilities & Equity
1,2331,2011,3161,7601,7691,832

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Total Debt
509351375283277286
Net Cash (Debt)
-287-156-55127616816
Net Cash Growth
----79.38%-24.51%42.41%
Net Cash Per Share
-2.22-1.22-0.410.934.435.37
Filing Date Shares Outstanding
118.01125.07124.66136.35136.48140.49
Total Common Shares Outstanding
118125125136.53136.48140.49
Working Capital
-143-262-97-24240640
Book Value Per Share
-1.76-0.78-2.70-1.400.371.44
Tangible Book Value
-210-100-343-204-19121
Tangible Book Value Per Share
-1.78-0.80-2.74-1.49-0.140.86
Land
9111176655155
Machinery
697676778077
Construction In Progress
70643823--
SEC Filings: 10-K · 10-Q